Botulinum Toxin-Type A: Could It Be an Effective Treatment Option in Intractable Trigeminal Neuralgia?

Journal of Headache and Pain - Italy
doi 10.1186/1129-2377-14-92
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Single-Dose Botulinum Toxin Type a Compared With Repeated-Dose for Treatment of Trigeminal Neuralgia: A Pilot Study

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2017English

Acth Is a Rescue Treatment for Intractable Trigeminal Neuralgia

2019English

Could Cannabidiol Be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?

Journal of Epilepsy Research
2017English

Central Antinociceptive Activity of Peripherally Applied Botulinum Toxin Type a in Lab Rat Model of Trigeminal Neuralgia

SpringerPlus
Multidisciplinary
2016English

Therapeutic Effect of Botulinum Toxin-A in 88 Patients With Trigeminal Neuralgia With 14-Month Follow-Up

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2014English

Refractory Urticarial Vasculitis Responsive to Methotrexate: Could It Be a New Treatment Option?

Clinical and Experimental Health Sciences
2019English

Peripheral Neurectomy of Inferior Alveolar Nerve – A Treatment Option for Trigeminal Neuralgia: A Case Report

Scholars Journal of Dental Sciences
2016English

Botulinum Toxin Type a Versus Botulinum Toxin Type B for Cervical Dystonia

2003English

Clostridium Botulinum Toxin Type A

Science-Business eXchange
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy